Abstract
The focus of this chapter is on the complex relationship between signs and symptoms, as an analog and therefore continuation of my discussion of the relationship between objective and subjective indicators. I discuss the figurative language used to express signs and symptoms, and a history of the development of the concept of objectivity. A final major topic covers the role of subjectivity in clinical medicine, and includes a discussion of the difference between clinimetric and psychometric assessments.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
Of course, a person’s heart rate, blood pressure, or blood chemistries could become part of a quality assessment, these symptoms are qualified (i.e., a person indicates the importance these indicators have for them). Evidence that this occurs naturally can be confirmed when respondents claim that various signs are impeding their quality-of-life.
- 2.
I will limit my discussion in this chapter to the assessment of a sign or symptom, and discuss how sign or symptom domains are formed in Chaps. 6 and 7.
- 3.
The term “objectification” has another use different from how I am using it. In the alternative usage, objectification refers to the phenomenon that a person views his or her body as an object; something outside themselves (Fredrickson and Roberts 1997). This has been associated with the presence or eating disorders, particularly for women.
- 4.
As will be discussed, “Grounded Field Theory” as an example of a qualitative assessment method, can reliably extract information from available data (e.g., interviews) and generate statements that have some of the properties of an invariant statement. This is so even though invariant statements generated from qualitative data may differ from those generated from quantitative data.
- 5.
In Chap. 10, I provide another example of a neurological (dementia) deterioration and what it does to artistic expression.
- 6.
This same question can be asked when establishing the relationship between symptoms and HRQOL. Is it the similarity, prototypicality, or exemplariness of features of a symptom that determines its relationship to HRQOL?
- 7.
Mensuration refers to assessment, but the part of assessment or geometry concerned with ascertaining lengths, areas, and volumes. It originates from the Latin, “from mensurare” or “to measure.”
- 8.
The Kaplan et al. (2000) paper was published prior to the Sullivan paper, but both are responding to a general debate that pervades medical science, to which Feinstein has made significant contributions.
- 9.
Defining and monitoring adverse events is a fairly complicated field involving several alternative definitions of what is adverse; application sites (e.g., clinical trials, postmarketing surveillance); settings (e.g., research or clinical); and type of intervention (e.g., drugs, biological agents, various device, so on). There are also different agencies involved in this type of activity, such as the World Health Organization, the Food and Drug Administration, the European Union, etc. The WHO organization definition of adverse events is “An injury related to medical management, in contrast to complications of disease. Medical management includes all aspects of care, including diagnosis and treatment, failure to diagnose or treat, and the systems and equipment used to deliver care. Adverse events may be preventable or nonpreventable.” (WHO 2005; p. 8).
- 10.
The issue of explicit and implicit valuations is a topic I will continue to discuss in this book. There are many more instances of implicit valuations, as opposed to formal explicit valuations, and the extent of this should reinforce the cognitive model of quality assessment being promoted in this book.
- 11.
A typical dose-escalation protocol would have three subjects being exposed to a particular dose, until at least one person experiences a toxic response. Then three more people are exposed to the dose, and if none of the participants respond to this dose, they are exposed to the next higher dose, but if one of the three did respond, then the MTD would be said to have been reached. Dose-finding, however, is not unique to Phase I trials, since it is also found in Phase II and III, as well as in clinical practice.
- 12.
At the time of presentation of this paper (October 1990), there were only two papers published that supported my argument: Berkel et al. (1988), which I was not aware of and did not cite; and an abstract by Melink et al. (1985), which I cited, and which was eventually published as a full paper in 1992.
- 13.
The “line of equality” is a 45-degree angle with the origin at 0,0.
Abbreviations
- AE:
-
Adverse events
- BFI:
-
Brief fatigue inventory (Mendoza et al. 1999)
- BPI:
-
Brief pain inventory (Cleeland 1989)
- CES-D:
-
Center for epidemiology scale – depression (Radloff 1977)
- CTCAE:
-
Common terminology criteria for adverse events
- FACT-G:
-
Functional assessment of cancer treatment – general (Cella et al. 1993)
- FACT-P:
-
Functional assessment of cancer treatment – prostate (Esper et al. 1997)
- HRQOL:
-
Health-related quality-of-life
- HUI:
-
Health Utility Index (Torrance et al. 1995)
- IES:
-
Impact of Event Scale (Horowitz et al. 1979)
- LC:
-
Local control
- LCSS:
-
Lung Cancer Symptom Scale (Hollen et al. 1993)
- QLQ-30C:
-
Quality-of-life questionnaire for cancer (Aaronson et al. 1991)
- Q-TwiST:
-
Quality-adjusted time without symptoms and toxicity
- QWB:
-
Quality of Well-being Scale (Kaplan and Anderson 1990)
- REL:
-
Relapse
- SF-36:
-
Short Form-36 (Ware et al. 1993)
- TOI:
-
Summary measure of physical well-being, functional well-being, and disease-specific overall score from disease-specific FACT assessments
- TOX:
-
Toxicity
References
Aaronson NK, Ahmedzai S, Bullinger M, Crabeels D, et al. (1991). The EORTC core quality-of-life questionnaire: Interim results of an international field study. In, (Ed.) D. Osoba, The Effect of Cancer on Quality-of-life. Boca Raton FL: CRC Press. (p. 185–203).
Ádám G. (1980). Perception, Consciousness, Memory; Reflections of a Biologist. New York NY: Plenum.
Alexander F. (1950). Psychosomatic Medicine. New York NY: Norton.
Alexander S, French T, Pollock G. (1968). Psychosomatic Specificity. Chicago IL: University of Chicago Press.
Apgar V. (1953). Proposal for a new method evaluation of the newborn infant. Anesthesiol Analg. 32, 260–267.
Badr H, Basen-Engquist K, Taylor CLC, de Moor C. (2006). Mood states associated with transitory physical symptoms among breast and ovarian cancer survivors. J Behav Med. 29, 461–475.
Bakal D, Coll P, Schaefer J. (2008). Somatic awareness in the clinical care of patients with body distress symptoms. Bio Psycho Soc Med. 2:6 doi:10.1186/1571-0759-2-6.
Barofsky I. (1993). Integrating quality-of-life assessments into Phase I clinical trials. In, (Eds.) CD Furberg, JA Schulttinger, SA Shumaker, NK Wenger. Quality-of-life Assessment: Practice, Problems, and Promise. Proceedings of a Workshop, October 15–17, 1990. National Institutes of Health. (p. 47–49).
Barsky AJ, Borus JF. (1999). Functional somatic syndromes. Ann Inter Med. 30, 910–921.
Bech P. (2004). Modern psychometrics in clinimetrics: Impact on clinical trials of antidepressants. Psychother Psychosom. 73: 134–138.
Bech P, Cialdella P, Haugh M, Birkett MA, et al. (2000). A meta-analysis of randomized controlled trials of fluoxetine versus placebo and tricyclic antidepressants in the short-term treatment of major depression. Brit J Psychiatr. 176, 421–428.
Berkel WG, Knopf H, Fromm M, et al. (1988). Influence of phase I clinical trials on quality-of-life of cancer patients. Anticancer Res. 8, 313–322.
Bilsbury CD, Richman A. (2002). A staging approach to measuring patient-centered subjective outcomes. Acta Psychiatr Scand. 106, 5–40.
Bland JM, Altman DG. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1: 307–310.
Blanton H, Jaccard J. (2006). Arbitrary metrics in psychology. Am Psychol. 61, 27–41.
Bollen K, Lennox R. (1991). Conventional wisdom on measurement: A structural equation perspective. Psychol Bull. 110, 305–314.
Boroditsky L. (2001). Does language shape thought? Mandarin and English speakers conceptions of time. Cogn Psychol. 43, 1–22.
Borsboom D. (2005). Measuring the Mind: Conceptual Issues in Contemporary Psychometrics. Cambridge UK: Cambridge University Press.
Brauer M, Chambres P, Niedenthal PM, Chatard-Panetier A. (2004). The relationship between expertise and evaluative extremity: The moderating role of experts task characteristics. J Pers Soc Psychol. 86, 5–18.
Bridgman PW. (1959). The Way Things Are. New York NY: Viking.
Cantor N, Smith EE, de sales French R, Mezzich J. (1980). Psychiatric diagnosis as prototype categorization. J Abnorm Psychol. 89, 181–193.
Cella DF. (1997). The Functional Assessment of Cancer Therapy-Anemia (Fact-An) scale: A new tool for the assessment of cancer anemia and fatigue. Semin Hematol. 34 (3, Suppl 2), 13–19.
Cella DF, Tulsky DS, Gray G, Sarafian B, et al. (1993). The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure. J Clin Oncol. 11, 570–579.
Chang CH, Cella DF, Clarke S, Heinemann AW, et al. (2003). Should symptoms be scaled for intensity, frequency or both? Palliation Support Care 1, 51–60.
Cleeland CS. (1989). Measurement of pain by subjective report. In, (Eds.) CR Chapman, JD Losser. Advances in Pain Research and Therapy. Vol.12 Issues in Pain Measurement. New York NY: Raven Press. (p. 391–403).
Cleeland CS. (2007). Symptom burden: multiple symptoms and their impact as patient-reported outcomes: Review. J Nat’l Cancer Inst Monogr. 37, 16–21.
Cleeland CS, Mendoza TR, Wang XS, Chou C, et al. (2000). Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer. 89, 1634–1646.
Cohen L, Parker PA, Sterner J. de Moor C. (2002a). Quality-of-life in patients with malignant melanoma participating in Phase I trial of an autologous turmor-derived vaccine. Melanoma Res. 12, 505–511.
Cohen L, de Moor C, Parker PA, Amato RJ. (2002b). Quality-of-life of patients with metastatic renal cell carcinoma participating in a Phase I trial of an autologous tumor derived-vaccine. Urol Oncol. 7, 119–124.
Cronbach LJ, Meehl PE. (1955). Construct validity and psychological tests. Psychol Bull. 52, 281–302.
CTCAE. (2006). The National Cancer Institute Cancer Therapy Evaluation Program (CTCAE v3.0); August 9th 2006 (http://ctep.cancer.gov/reporting/ctcHTML).
Daston L, Galison P. (2007). Objectivity. New York NY: Zone Books.
Dawes RM, Faust D, Meehl PE. (1989). Clinical versus actuarial judgment. Science. 243, 1668–1674.
De Vet HCW, Terwee CB, Bouter LM. (2003a). Current challenges in clinimetrics. J Clin Epidemiol. 56, 1137–1141.
De Vet HCW, Terwee CB, Bouter LM. (2003b). Clinimetrics and psychometrics: two sides of the same coin. J Clin Epidemiol. 56, 1146–1147.
Embretson SE. (2006). The continued search for nonarbitrary metrics in psychology. Am Psychol. 61, 50–55.
Epstein SK. (2007). Weaning the “unweanable”: Liberating patients from prolonged mechanical ventilation. Crit Care Med. 335, 2640–2641.
Escobar JI, Gara MA, Diaz-Martinex AM, Interian A, et al. (2007). Effectiveness of a time-limited cognitive behavior therapy-type intervention among primary care patients with medically unexplained symptoms. Annu Fam Med. 5, 328–335.
Esper P, Mo F, Chodak G, Sinner M, et al. (1997). Measuring quality-of-life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate (FACT-P) instrument. Urology. 50, 920–928.
Esterling D, Leventhal H. (1989). Contribution of concrete cognition to emotion neural symptoms as elicitors of worry about cancer. J Appl Psychol. 74, 787–796.
Estey E, Hoth D, Simon R, Marsoni S, et al. (1986). Therapeutic response in Phase I trials in antineoplastic agents. Cancer Treat Rep. 70, 1105–1115.
Eva KW, Cunnington JP. (2006). The difficulty experience: Does practice increase susceptibility to premature closure. J Continu Educ Health Prof. 26, 192–198.
Fava GA, Belaisea C. (2005). A discussion on the role of clinimetrics and the misleading effects of psychometric theory. J Clin Epidemiol. 58, 753–756.
Fava GA, Ruini C, Rafanelli C. (2004). Psychometric theory is an obstacle to progress of clinical research. Psychother Psychosom. 73, 145–148.
Fayers PM, Hand DJ. (2002). Causal variables, indicator variables and measurement scales: An example from quality-of-life. J R Soc Stat. 165, 233–261.
Fayers PM, Hand DJ. (1997). Factor analysis, causal indicators and quality of life. Qual Life Res. 6, 139–150.
Feinstein A. (1967). Clinical Judgment. Huntington NY: Krieger
Feinstein AR. (1987a). Clinimetric perspective. J Chronic Dis. 40, 635–640.
Feinstein AR. (1987b). Clinimetrics. New Haven NY: Yale.
Ferrans CE. (1990). Development of a quality-of-life index for patients with cancer. Oncol Nurs Forum. 17, 29–38.
Ferrans CE. (2007). Differences in what Quality-of-Life instruments measure. J Nat’l Cancer Inst Monogr. 37, 1–9.
Fink P, Toft T, Hansen MS, Ørnbol E, et al. (2007). Symptoms and syndromes of bodily distress: An explanatory study of 987 internal medical neurological, and primary care patients. Psychosom Med. 69, 30–39.
Fleishman SB. (2004). The treatment of symptom clusters: Pain, depression and fatigue. J Nat’l Cancer Inst Monogr. 32, 119–123.
Folstein MF, Folstein SE, McHugh PR. (1975) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12: 189–198.
Fredrickson BL, Roberts T-A. (1997). Objectification Theory: Towards understanding women’s lived experiences and mental health risks. Psychol Women Q. 21, 173–206.
Frege, G. (1892/1966). On Concept and Object, in (eds.) P. Geach, M. Black, Translations from Philosophical Writings of Gottlob Frege. Oxford UK: Oxford University Press. (p. 42).
Gelber RD, Goldhirsch A, and the Ludwig Breast Cancer Group. (1986). A new endpoint for the assessment of operable breast cancer. J Clin Oncol. 4, 1772–1779.
Gelber RD, Goldhirsch A. (1989). Comparison of adjuvant therapies using quality-of-life considerations. Int J Technol Assess Health Care. 5(3):401–413.
Gendolla GHE, Abele A, Prurk D, Richter M. (2005). Negative mood, self-focused attention and the experience of physical symptoms: The Joint Impact Hypothesis. Emotion. 5, 131–144.
Gerber LR. (2008). Targeted therapies: A new generation of cancer treatments. Am Fam Physician.77, 311–319
Gijsbers van Wijk CMT, Kolk AM. (1997). Sex differences in physical symptoms: The contribution of symptom perception theory. Soc Sci Med. 45, 231–246.
Gill TM, Feinstein AR. (1994). A critical appraisal of the quality of quality-of-life measurements. JAMA. 272, 619–626.
Giraldo B, Garde A, Benito JS, Diaz J, Ballesteros D. (2006). Support vector machine classification applied on weaning trials patients. Proceedings of the 28 th IEEE EMBS Annual International Conference, New York City, USA, August 30-September 3, 2006. Accessed from the Web 12/28/2007.
Glannon W. (2006). Phase I oncology trials: Why the therapeutic misconception will not go away. J Med Ethics. 32, 252–255.
Glaser BG. (1992). Emergence vs Forcing: Basics of Grounded Theory Analysis. Mill Valley, CA: Sociology Press.
Glaser BG, with the assistance of Holton J. (2004). Remodeling grounded theory. Forum Qual Soc Res. 5(2), Art. 4. Available at: http://www.qualitative-research.net/fgs-texte/2-04glaser-e.htm. (Assessed; 12/20/2007).
Glaser BG, Strauss A. (1967). The Discovery of Grounded Theory: Strategies for Qualitative Research. New York NY: Aldine.
Goldberg LR. (1991). Human mind versus regression equation: Five contrasts. In, (Eds.) D Cicchetti, DE Gerber. Thinking Clearly About Psychology: Essays in Honor of Paul E. Meehl. Minneapolis Minnesota: University of Minnesota Press.
Gottschalk A, Hyzer C, Geer RT. (2000). A comparison of human and machine-based predictions of successful weaning from mechanical ventilation. Med Decis Mak. 20, 160–169.
Gram LF, Bech P. Reisby N, Jørgenson OS. (1981). Methodology in studies on plasma level/effect relationships of tricyclics antidepressants. In, (Ed.) E. Usdin Clinical Pharmacology in Psychiatry. Amsterdam, North-Holland:Elsevier. (p. 155–171).
Grove WM, Meehl PE. (1996). Comparative efficiency of informal (subjective, impressionistic) and formal (mechanical, algorithmic) prediction procedures: The clinical-statistical controversy. Psychol Public Policy Law. 2, 293–323.
Haig TH, Scott DA, Stevens GB. (1989). Measurement of the discomfort component of illness. Med Care. 27, 280–287.
Hammond KR, Stewart TR, Brehmer B, Steinmann DO. (1975). Social Judgment Theory. In, (Eds.) MF Kaplan, S Schwartz. Human Judgment and Decision Processes: Formal and Mathematical Approaches. New York NY: Academic Press. (p. 272–312).
Heath H, Cowley S. (2004). Developing a grounded theory approach: a comparison of Glaser and Strauss. Int J Nurs Stud. 41, 141–150.
Helmholtz H. (1869/1954). On the Sensation of Tone as a Physiological Basis for the Theory of Music. Mineola NY: Dover Publishing.
Henderson GE, Easter MM, Zimmer C, King NMP, et al. (2006). Therapeutic misconception in early phase gene transfer trials. Soc Sci Med. 62, 239–253.
Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. (1993). Quality-of-life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 29A, S51–S58.
Hollen PJ, Gralla RJ, Rittenberg CN. (2004). Quality-of-life as a clinical trial endpoint: Determining the appropriate interval for repeated assessment in patients with advanced lung disease. Support Care Cancer. 12, 767–773.
Horowitz M, Wilner N, Alvarez W. (1979). Impact of events scale: Measure of subjective stress. Psychosom Med. 41, 209–218.
Horstmann E, McCabe MS, Grochow L, Yamamoto S, Rubinstein L, et al. (2005). Risks and benefits of Phase I oncology trials 1991 through 2002. NEJM. 352, 895–904.
Issell BF, Gotay CC, Pagano IS. (2007). Quality-of-life assessment in a Phase I trial of noni. Poster presentation at the 12th Annual Conference of the International Society for Quality-of-life Research, San Francisco, CA. (October, 2007)
Jairath N. (1999). Myocardial infarction patients’ use of metaphors to share meaning and communicate their frame of reference. J Adv Nurs. 29, 283–289.
Jonas DL, Kline Leidy N, Siberman C, Margolis MK, Heyes A. (2001). Cognitive factors in symptom assessment: Are we asking too much? Abstract Presented at the Annual Meeting of the International Society of Quality-of-life Research, Amsterdam The Netherlands. 2001. Qual Life Res. 10, 274.
Jones RA, Weise HJ, Moore RW, Haley JV. (1981). On the perceived meaning of symptoms. Med Care. 19, 710–717.
Juniper EF, Guyatt GH, Streiner DL, King DR. (1997). Clinical impact versus factor analysis for quality-of-life questionnaire construction. J Clin Epidemiol. 50, 233–238.
Kaplan EL, Meier P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53, 457–481.
Kaplan RM, Anderson JP. (1990). The General Health Policy Model: An integrated approach. In, (Ed.) B Spilker. Quality-of-life Assessments in Clinical Trials. New York NY: Ravens. (131–149).
Kaplan SH, Kravitz RL, Greenfield S. (2000). A critique of current uses of health status for the assessment of treatment effectiveness and quality of care. Med Care. 38 (Supp. II), 184–191.
Kazdin AE. (2006). Arbitrary metrics: Implications for identifying evidence-based treatments. Am Psychol. 61, 42–49.
Kim NS, Ahn W-K. (2002). Clinical psychologists’ theory-based representations of mental disorders predict their diagnostic reasoning and memory. J Exp Psychol: Gen. 131, 451–476.
Kirkiva J, Davis MP, Walsh D, Tiernan E, et al. (2006). Cancer symptom assessments instruments: A systematic review. J Clin Oncol. 24, 1459–1473.
Kleinmuntz B. (1990). Clinical and actuarial judgment. Sci. 247, 146.
Koop RR. (1995). Metaphor Therapy: Using Client Generated Metaphors in Psychotherapy. Bristol PA: Brunner-Mazel.
Kövecses Z. (2000). Metaphors and Emotion: Language, Culture and Body in Human Feeling. Cambridge UK: Cambridge University Press.
Kushniruk AW, Patel VL, Marley AAJ. (1998). Small worlds and medical expertise: Implications for medical cognition and knowledge engineering. Int J Med Inf. 49, 255–271.
Lakoff G, Johnson M. (1999). Philosophy in the Flesh: The Embodied Mind and its Challenge to Western Thought. New York NY: Basic Books.
Lau HC, Rogers RD, Haggard P, Passingham RE. (2004). Attention to intention. Science. 303, 1208–1210.
Lawton MP. (1991). A multidimensional view of quality-of-life in frail elderly. In, (Eds.) JE Birren, JE Lubben, JC Rowe, DE Deutchman. The Concept and Measurement of Quality-of-life in Frail Elderly. New York NY: Academic Press. (p. 3–27).
Lazarus RS. (1991). Emotion and Adaptation. New York NY: Oxford University Press.
Leventhal EA, Hansell S, Diefenbach M, Leventhal H, et al. (1996). Negative affect and self-report of physical symptoms: Two longitudinal studies of older adults. Health Psychol. 15, 193–199.
Levine MN, Guyatt GH, Gent M, De Pauw S, et al. (1988). Quality-of-life in Stage II breast cancer: An instrument for clinical trials. J Clin Oncol. 6,1798-1810.
Lim SJ, Cormier JN, Feig BW, Mansfield PF, et al. (2007). Toxicity and outcomes associated with surgical cytoreduction and hypertermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol. 14, 2309–2318.
Lipowski ZJ. (1984). What does the word “psychosomatic” really mean? A historical and semantic inquiry. Psychosom Med. 46, 152–171.
Lord F. (1953). On the statistical treatment of football numbers. Am Psychol. 8, 750–751.
LoRusso PM, Herbst RS, Rischin D, Ranson M, et al. (2003). Improvements in quality-of-life and disease-related symptoms in Phase I trials of selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. Clin Cancer Res. 9, 2040–2048.
Marx RG, Bombardier, Hogg-Johnson S, Wright JG. (1999). Clinimetric and psychometric strategies for development of a health measurement scale. J Clin Epidemiol. 52, 105–111.
Marx RG, Bombardier C, Hogg-Johnson S, Wright JG. (1999). How should importance and severity ratings be combined for item reduction in the development of health status instruments? J Clin Epidemiol. 52, 193–197.
McCorkle R, Young K. (1978). Development of a symptom distress scale. Cancer Nurs. 1, 373–378.
McCrae RR, Bartone PT, Costa PT. (1976). Age, anxiety and self-related health. Aging Hum Dev. 7, 49–58.
Meehl PE. (1954). Clinical Versus Statistical Prediction. Minneapolis MN: University of Minnesota Press.
Mendoza T, Wang XS, Cleeland CS, Morrissey M, et al. (1999). The Rapid Assessment of Fatigue Severity in Cancer Patients: Use of the Brief Fatigue Inventory. Cancer. 85, 1186–1196.
Melhem A, Stern M, Shibolet O, Isreali E, et al. (2005). Treatment of chronic Hepatitis C virus vai antioxidants: Results of a Phase I clinical trial. J Clin Gastroenterol. 39, 737–742.
Melink TJ, von Hoff DD, Clark GM, Coltman CA. (1985). Impact of Phase I clinical trial trials on the quality-of-life and survival of cancer patients. Proc Am Soc Clin Oncol. 4, 251.
Melink TJ, Clark GM, von Hoff DD. (1992). The impact of Phase I clinical trials on the quality-of-life of patients with cancer. Anti-Cancer Drugs. 3, 571–576.
Melzack R, Katz J. (1992). The McGill Pain Questionnaire: Appraisal and current status. In, (Eds.) DC Turk, R Melzack. Handbook of Pain Assessment. New York NY: Guilford. p. 152–168.
Michael M, Wirth A, Ball DL, MacManus M, et al. (2005). A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC. Brit J Cancer. 93, 652–661.
Morris R, Dowrick C, Salomon P, Peters S, et al. (2007). Cluster randomized controlled trial of training practices in reattributions for medically unexplained symptoms. Brit J Psychiatr. 191, 536–542.
Murphy ST, Zajonc RB. (1993) Affect, cognition and awareness affective priming with optimal and suboptimal stimulus exposures. J Personal Soc Psychol. 64, 723–739.
Nagel T. (1986). The View from No Where. New York NY: Oxford University Press. (p. 5).
National Institutes of Health: State-of-the-Science Conference Statement. (2004). Symptom management in cancer: Pain, depression and fatigue, July 15–17, 2002. J Nat’l Cancer Inst Monogr. 32, 9–16.
Nierenberg AA, Sonino N. (2004). From clinical observations to clinimetrics: A tribute to Alvan R. Feinstein, MD. Psychother Psychosom. 73, 131–133.
Norman G, Eva K, Brooks L, Hamstra S. (2006). Expertise in medicine and surgery. In, (Eds.) CN Ericsson, R Hoffman, Feltovich PJ. Cambridge Handbook of Expertise and Expert Performance. New York NY: Cambridge University Press. (p. 339–353).
Otis AS. (1917). A criticism of the Yerkes-Bridges Point Scale, with alternative suggestions. J Educ Psychol. 8, 129–150.
Oxford English Dictionary. (1996). Oxford, UK: Oxford University Press.
Paice JA. (2004). Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr. 32, 98–102.
Palmer JL, Fisch MJ. (2005). Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manag. 29, 565–571.
Pennebaker JW. (1982). The Psychology of Physical Symptoms. New York NY: Springer-Verlag.
Pond GR, Siu LL, Moore M,Oza A, et al. (2008). Nomograms to predict serious adverse events in Phase II clinical trials of molecularly targeted agents. J Clin Oncol. 26, 1324–1330.
Portenoy RK, Thaler HT, Kornblith AB, McCarthy LJ, et al. (1994). The Memorial Symptom Assessment Scale: an instrument for the evaluation of the symptom prevalence, characteristics and distress. Eur J Cancer. 30A, 1326–1336.
Radloff LS. (1977). The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 3, 385–401.
Ranganath KA, Nosek BA. (2008). Implicit attitude generalization occurs immediately; Explicit attitude generalization takes time. Psychol Sci. 19, 249–254.
Rasch G. (1977). On specific objectivity: An attempt at formalizing the request for generality and validity of scientific statements. Dan Yearbook Philos. 14, 58–94.
Ratakonda S, Gorman JM, Yale SA, Amador XF. (1998). Characterization of psychotic conditions. Arch Gen Psychiatr. 55, 75–81.
Rees CE, Knight LV, Wilkinson CE. (2007). Doctors being up there and we being down here: A metaphoric analysis of talk about student/doctor-patient relationships. Soc Sci Med. 65, 725–737L.
Rehber B. (2003). Categorization as causal reasoning. Cogn Sci. 27, 709–748.
Ribera A, Permanyer-Miralda G, Alonzo J, Soriano N, Brotons C. (2006). Is psychometric scoring of the Mc New Quality-of-life questionnaire superior to the clinimetric scoring? A comparison of the two approaches. Qual Life Res. 15, 357–365.
Ritchie J. (1973). Pain from distention of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut. 14, 125–132.
Sacks O. (1985). The Man who Mistook his Wife for a Hat and Other Clinical Tales. New York NY: Summit Books.
Salmon P, Peters S, Clifford R, Iredale W, et al. (2007). Why do general practitioners decline training to improve management of medically unexplained symptoms? J Gen Inter Med. 22, 565–571.
Samarel N, Leddy SK, Greco K, Cooley ME, et al. (1996). Development and testing of the Symptom Experience Scale. J Pain Symptom Manag. 12, 221–228.
Sarkar S, Hobson AR, Furlong PL, Woolf CJ, et al. (2001). Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 281, G1196–1202.
Schuster MM, Crowell MD, Koch KL. (2002). Schuster Atlas of Gastrointestinal Motility in Health and Disease. Hamilton Canada BC: Decker.
Scriven M. (1979). Clinical judgment. In, (Eds.) HT Engelhardt Jr, SF Spricker, B. Towers, Clinical Judgment: A Critical Apprisal. Dordrecht Holland: Reidel.
Shamoo AE, Resnik DB. (2006). Strategies to minimize risks of exploitation in Phase I trials on healthy subjects. Am J Bioeth. 6, 1–13.
Shapiro MB. (1961). A method of measuring psychological change specific to the individual psychiatric patient. Brit J Med Psychol. 34, 151–155.
Singer T, Seymour B, O’Doherty J, Kaube H, et al. (2004). Empathy for pain involves affective but not sensory components of pain. Science. 303,1157-1162.
Singh AC, Bilsbury CD. (1989). Measurement of subjective variables: The Discan method. Acta Psychiatr Scad. 79 (Suppl 347), 1–38.
Skårderud F. (2007). Eating one’s words, Part I: ‘Concretized Metaphors’ and reflective function in anorexia nervosa – An interview study. Eur Eat Disord Rev. 15, 163–174.
Skelton JR, Wearn AM, Hobbs FD. (2002). A concordance-based study of metaphoric expressions used by general practitioners and patients. Brit J Gen Pract. 52, 114–118.
Skeat J, Perry A. (2008). Grounded theory as a method of research in speech and language therapy. Int J Lang Commun Disord. 43, 95–107.
Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, et al. (2001). Methodologic lessons learned from hot flash studies. J Clin Oncol. 19, 4280–4290.
Sontag S. (1991). Illness as Metaphor and AIDS and its Metaphors. New York NY: Picador USA.
Strauss A, Corbin J. (1998). Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks CA: Sage.
Streiner DL. (2003a). Clinimetrics vs, psychometrics: an unnecessary distinction. J Clin Epidemiol. 56, 1142–1145.
Streiner DL. (2003b). Test development: two-sided coin or one-sided Möbius strip? J Clin Epidemiol. 56, 1148–1149.
Streiner DL. (2003c). Being inconsistent about inconsistency: when coefficient alpha does and doesn’t matter. J Personal Assess. 80, 217–222.
Sullivan M. (2003). The new subjective medicine: Taking the patient’s point of view on health care and health. Soc Sci Med. 56, 1595–1604.
Tehrani FT. (2007). A new decision support system for mechanical ventilation. Proceedings of the 29th Annual International Conference of the IEEE EMBS Cité Internationale, Lyon, France. August 23–26, 2007. Accessed from the Web, 12/28/2007.
Tessler R, Mechanic D. (1978). Psychological distress and perceived health status. J Health Soc Behav. 19, 254–262.
Tester W, Ackler J, Tijani L, Leighton J. (2006). Phase I/II study of weekly docetaxel and vinblastine in the treatment of metastatic hormone-refractory prostate cancinoma. Cancer J. 12, 299–304.
Thurstone LL. (1927). A law of comparative judgment. Psychol Rev. 34, 273–286.
Thurstone LL. (1928). The absolute zero in measurement of intelligence. Psychol Rev. 35, 175–197.
Tishelman C, Degner LF, Rudman A, Bertilsson K, et al. (2005). Symptoms in patients with lung carcinoma: distinguishing distress from intensity. Cancer. 104, 2013–2021.
Tishelman C, Petersson L-M, Degner LF, Sprangers MAG. (2007). Symptom prevalence. intensity, and distress in patients with inoperable lung cancer in relation to time of death. J Clin Oncol. 25, 5381–5389.
Torrance GW, Furlong W, Feeny D, Boyle M. (1995). Multi-attribute preference functions: Health Utilities Index. Pharm Econ. 7, 503–520.
Townsend JT, Ashby FG. (1984). Measurement scales and statistics: The misconception misconceived. Psychol Bull. 96, 394–401.
Verbrugge L. (1989). The twain meet: Empirical explanations of sex differences in health and mortality. J Health Soc Behav. 30, 282–304.
Verbrugge L, Ascione FJ. (1987). Exploring the iceberg: Common symptoms and how people care for them. Med Care. 25, 539–569.
Walsh D, Rybicki L. (2006). Symptom clustering in advanced cancer. Support Care Cancer. 14, 832–836.
Ware JE, Snow KK, Kosinski MA, Gandek B. (1993). SF-36 Health Survey: Manual and Interpretation Guide. Boston MA: The Health Institute, New England Medical Center.
Watson D. (1988). Intra-individual and inter-individual analysis of positive and negative affect; Their relation to health complaints, perceived stress and daily activities. J Personal Soc Psychol. 54, 1020–1030.
Watson D, Pennebaker JW. (1989). Human complaints, stress, and distress: Exploring the central role of negative affectivity. Psychol Rev. 96, 234–254.
Wearden AJ. (2005). Adult attachment, alexithymia, and symptom resporting: An extension of the four category model of attachment. J Psychosom Res. 58, 279–288.
Weiss R. (2007). Synthetic DNA on the brink of yielding new life forms. Washington Post December 17, 2007. Accessed on the web; http://www.washingpost.com/wp-dyn/content/article/2007/12/16/2007. December 17, 2007 at 11:36 AM
Westen D, Weinberger J. (2004). When clinical descriptions become statistical predictions. Am Psychol. 59,595-613.
Whitehead WE, Holtkotter B, Enck P, Hoelzl R, et al. (1990). Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterol. 98, 1187–1192.
Wilson IB, Cleary PD. (1995). Linking clinical variables with health-related quality-of-life: A conceptual model of patient outcomes. JAMA. 273, 59–65.
Woolf CJ, Salter MW. (2000). Neuronal plasticity: Increasing the gain in pain. Science. 288, 1765–1769.
Woolrich RA, Cooper MJ, Turner HM. (2008). Metacognition in patients with anorexia nervosa, dieting and non-dieting women: A preliminary study. Eur Eat Disorders Rev. 16, 11–26.
World Health Organization Draft Guidelines for Adverse Event Reporting and Learning Systems. (2005). Geneva Switzerland: WHO. (p. 8).
Yunus MB. (2008). Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 37, 339–52.
Zimmerman J. (2003). Cleaning up the river: A metaphor for functional digestive disorders. Am J Hypn. 45, 353–359.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Barofsky, I. (2012). The Role of Signs or Symptoms. In: Quality. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9819-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9819-4_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9818-7
Online ISBN: 978-1-4419-9819-4
eBook Packages: MedicineMedicine (R0)